-
-
-
-
-
-
-
RedHill Received Talicia® Licensing Payments Totaling $1.1 Million
-
-
-
-
-
-
-
RedHill Biopharma (RDHL) and Medi-Cal Deal Maintains Talicia® Reimbursement Without Prior Authorization for 15 Million Californians
-
-
-
-
-
-
-
RedHill (RDHL) and U.S. Army Report Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola
-
-
-
-
-
-
-
RedHill Biopharma (RDHL) Announces RDHL Opaganib Selected by NIH RNCP For Development
-
-
-
-
-
-
-
RedHill Presents New Talicia® Data Analyses at Obesity Week 2022
-
-
-
-
-
-
-
RedHill Biopharma (RDHL) Announces Publication Showing Consistent Efficacy of Talicia Irrespective of Patient BMI
-
-
-
-
-
-
-
RedHill Biopharma's Talicia® added to Medi-Cal Contract Drug List with No Prior Authorization Requirements
-
64,524 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

